Runx2 Regulates Galnt3 and Fgf23 Expressions and Galnt3 Decelerates Osteoid Mineralization by Stabilizing Fgf23

Qing Jiang,Xin Qin,Takeshi Moriishi,Ryo Fukuyama,Shinichi Katsumata,Hiroshi Matsuzaki,Hisato Komori,Yuki Matsuo,Chiharu Sakane,Kosei Ito,Hironori Hojo,Shinsuke Ohba,Toshihisa Komori

DOI: https://doi.org/10.3390/ijms25042275

IF: 5.6

2024-02-15

International Journal of Molecular Sciences

Abstract:Runx2 (runt related transcription factor 2) is an essential transcription factor for osteoblast proliferation and differentiation. Uridine diphosphate (UDP)-N-acetylgalactosamine (GalNAc): polypeptide GalNAc-transferase 3 (Galnt3) prevents proteolytic processing of fibroblast growth factor 23 (Fgf23), which is a hormone that regulates the serum level of phosphorus. Runx2 and Galnt3 were expressed in osteoblasts and osteocytes, and Fgf23 expression was restricted to osteocytes in bone. Overexpression and knock-down of Runx2 upregulated and downregulated, respectively, the expressions of Galnt3 and Fgf23, and Runx2 directly regulated the transcriptional activity of Galnt3 in reporter assays. The expressions of Galnt3 and Fgf23 in osteoblast-specific Runx2 knockout (Runx2fl/flCre) mice were about half those in Runx2fl/fl mice. However, the serum levels of phosphorus and intact Fgf23 in Runx2fl/flCre mice were similar to those in Runx2fl/fl mice. The trabecular bone volume was increased during aging in both male and female Galnt3−/− mice, but the osteoid was reduced. The markers for bone formation and resorption in Galnt3−/− mice were similar to the control in both sexes. Galnt3−/− mice exhibited hyperphosphatemia and hypercalcemia, and the intact Fgf23 was about 40% that of wild-type mice. These findings indicated that Runx2 regulates the expressions of Galnt3 and Fgf23 and that Galnt3 decelerates the mineralization of osteoid by stabilizing Fgf23.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper attempts to address the issue of how Runx2 (a transcription factor that plays a key role in osteocyte proliferation and differentiation) regulates the expression of Galnt3 and Fgf23, and the mechanism by which Galnt3 delays the mineralization of bone-like tissue by stabilizing Fgf23. Specifically, the researchers focused on the following aspects:

1. **Regulation of Galnt3 and Fgf23 expression by Runx2**: The researchers experimentally verified whether Runx2 can upregulate or downregulate the expression of Galnt3 and Fgf23, and explored the specific mechanisms of this regulation.

2. **Role of Galnt3 in bone development and maintenance**: The researchers analyzed the skeletal phenotype of Galnt3 knockout mice (Galnt3−/−) to understand the specific function of Galnt3 in bone development and maintenance.

3. **Regulation of phosphate homeostasis**: The researchers investigated the roles of Runx2 and Galnt3 in the regulation of phosphate homeostasis, particularly how they affect serum phosphate levels and the levels of intact Fgf23.

Through these studies, the paper aims to reveal the interactions between Runx2, Galnt3, and Fgf23 in bone metabolism and their impact on bone health.